FBRX – Forte Biosciences Inc
Float Short %
6.32
Margin Of Safety %
Put/Call OI Ratio
1.08
EPS Next Q Diff
0.01
EPS Last/This Y
7.85
EPS This/Next Y
0.53
Price
29.09
Target Price
63.75
Analyst Recom
1
Performance Q
61.6
Upside
-436.4%
Beta
3.23
Ticker: FBRX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-23 | FBRX | 31.26 | 0.77 | 0.00 | 547 |
| 2026-01-26 | FBRX | 32.57 | 0.73 | 0.00 | 564 |
| 2026-01-27 | FBRX | 35.34 | 0.74 | 0.00 | 561 |
| 2026-01-28 | FBRX | 29.74 | 0.73 | 4.25 | 562 |
| 2026-01-29 | FBRX | 29.05 | 0.77 | 0.33 | 580 |
| 2026-01-30 | FBRX | 29.13 | 0.78 | 3.00 | 578 |
| 2026-02-02 | FBRX | 34.55 | 0.77 | 0.00 | 578 |
| 2026-02-03 | FBRX | 34.35 | 0.77 | 0.33 | 579 |
| 2026-02-04 | FBRX | 32.18 | 0.77 | 0.50 | 582 |
| 2026-02-05 | FBRX | 29.34 | 0.77 | 0.25 | 580 |
| 2026-02-06 | FBRX | 27.83 | 0.79 | 0.00 | 573 |
| 2026-02-09 | FBRX | 29.91 | 0.79 | 999.99 | 573 |
| 2026-02-10 | FBRX | 29.77 | 0.80 | 0.00 | 575 |
| 2026-02-11 | FBRX | 29.86 | 0.80 | 0.00 | 575 |
| 2026-02-12 | FBRX | 30.58 | 0.78 | 0.00 | 582 |
| 2026-02-13 | FBRX | 31.89 | 0.78 | 9.50 | 582 |
| 2026-02-17 | FBRX | 29.99 | 0.93 | 999.99 | 636 |
| 2026-02-18 | FBRX | 29.01 | 1.01 | 999.99 | 660 |
| 2026-02-20 | FBRX | 29.3 | 1.08 | 999.99 | 684 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-23 | FBRX | 31.74 | - | - | -4.32 |
| 2026-01-26 | FBRX | 32.67 | - | - | -4.32 |
| 2026-01-27 | FBRX | 35.34 | - | - | -4.32 |
| 2026-01-28 | FBRX | 29.74 | - | - | -4.32 |
| 2026-01-29 | FBRX | 29.30 | - | - | -4.32 |
| 2026-01-30 | FBRX | 29.18 | - | - | -4.32 |
| 2026-02-02 | FBRX | 34.74 | - | - | -4.32 |
| 2026-02-03 | FBRX | 34.37 | - | - | -4.32 |
| 2026-02-04 | FBRX | 32.06 | - | - | -4.32 |
| 2026-02-05 | FBRX | 28.86 | - | - | -4.32 |
| 2026-02-06 | FBRX | 27.66 | - | - | -4.32 |
| 2026-02-09 | FBRX | 29.78 | - | - | -4.32 |
| 2026-02-10 | FBRX | 29.48 | - | - | -4.32 |
| 2026-02-11 | FBRX | 29.86 | - | - | -4.32 |
| 2026-02-12 | FBRX | 30.58 | - | - | -4.32 |
| 2026-02-13 | FBRX | 31.46 | - | - | -4.32 |
| 2026-02-17 | FBRX | 29.81 | - | - | -4.32 |
| 2026-02-18 | FBRX | 29.19 | - | - | -4.32 |
| 2026-02-19 | FBRX | 29.66 | - | - | -4.32 |
| 2026-02-20 | FBRX | 29.09 | - | - | -4.32 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-23 | FBRX | 0.59 | 10.45 | 4.70 |
| 2026-01-26 | FBRX | 0.59 | 19.08 | 4.70 |
| 2026-01-27 | FBRX | 0.59 | 19.08 | 4.70 |
| 2026-01-28 | FBRX | 0.59 | 19.08 | 7.31 |
| 2026-01-29 | FBRX | 0.59 | 19.08 | 7.31 |
| 2026-01-30 | FBRX | 0.59 | 19.08 | 7.31 |
| 2026-02-02 | FBRX | 0.59 | 19.07 | 7.31 |
| 2026-02-03 | FBRX | 0.59 | 19.07 | 7.31 |
| 2026-02-04 | FBRX | 0.59 | 19.07 | 7.31 |
| 2026-02-05 | FBRX | 0.59 | 19.07 | 7.31 |
| 2026-02-06 | FBRX | 0.59 | 19.07 | 7.31 |
| 2026-02-10 | FBRX | 0.59 | 17.99 | 7.31 |
| 2026-02-11 | FBRX | 0.59 | 17.99 | 6.32 |
| 2026-02-12 | FBRX | 0.59 | 17.99 | 6.32 |
| 2026-02-13 | FBRX | 0.59 | 17.99 | 6.32 |
| 2026-02-17 | FBRX | 0.59 | 16.45 | 6.32 |
| 2026-02-18 | FBRX | 0.59 | 16.45 | 6.32 |
| 2026-02-19 | FBRX | 0.59 | 16.45 | 6.32 |
| 2026-02-20 | FBRX | 0.59 | 16.45 | 6.32 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.99
Avg. EPS Est. Current Quarter
-1.18
Avg. EPS Est. Next Quarter
-0.98
Insider Transactions
0.59
Institutional Transactions
16.45
Beta
3.23
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
8
Growth Score
19
Sentiment Score
60
Actual DrawDown %
97.3
Max Drawdown 5-Year %
-99.6
Target Price
63.75
P/E
Forward P/E
PEG
P/S
P/B
4.32
P/Free Cash Flow
EPS
-4.44
Average EPS Est. Cur. Y
-4.32
EPS Next Y. (Est.)
-3.78
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.82
Return on Equity vs Sector %
-90.5
Return on Equity vs Industry %
-73.1
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.12
EBIT Estimation
Forte Biosciences, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 16
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
stock quote shares FBRX – Forte Biosciences Inc Stock Price stock today
news today FBRX – Forte Biosciences Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FBRX – Forte Biosciences Inc yahoo finance google finance
stock history FBRX – Forte Biosciences Inc invest stock market
stock prices FBRX premarket after hours
ticker FBRX fair value insiders trading